No Data
Tian An Medicare's H1 Profit Surges as Revenue Grows
Tian An Medicare Posts Strong H1 2024 Growth
Tian An Health Group (00383) announced its interim results, with a net profit attributable to owners of 21.659 million Hong Kong dollars, an increase of about 15.53 times year-on-year.
Tian An China Investments Company Limited (00383) released its mid-term performance for 2024, with a total revenue of approximately 0.822 billion Hong Kong dollars, an increase of approximately...
Tian An Medicare Sets Key Board Meeting
Tian An Health InfoTech (00383.HK) plans to hold a board of directors meeting on August 2nd to approve its mid-term performance.
Tian An China Investments Company Limited (00383.HK) announced that the board of directors meeting will be held on August 2nd, 2024, Friday to approve the mid-term performance report from January 1st, 2024 to June 30th, 2024 inclusive and consider the payment of interim dividend (if any) of the company and its subsidiaries.
Guangdong Tianan New Material (603725.SH): Cumulative repurchase of 1.1974% of the company's shares.
Guangdong Tianan New Material (603725.SH) announced on July 9th that as of the disclosure date of this announcement, the company has completed the repurchase and has actually repurchased 3,650,320 shares of the company through centralized competitive trading, accounting for 1.1974% of the total share capital of the company. The repurchase transaction's highest price was 10.23 yuan/share (the repurchase price ceiling before the 2023 equity distribution ex-rights date was 14 yuan/share), the lowest price was 6.17 yuan/share, and the total transaction amount was 30,027,578.60 yuan (excluding transaction costs).
Not Many Are Piling Into Tian An China Investments Company Limited (HKG:28) Just YetNo Data
